Insulin Clinics / Foundations

Rapid-acting (mealtime) insulin

Mealtime insulin covers the rise in blood sugar from food. The products differ mainly in how quickly they start working — which decides how close to a meal they are taken.

Last updated: October 2026 · Based on ADA Standards of Care, FDA prescribing information, and NIDDK · General information, not medical advice — see our editorial policy

What mealtime insulin is for

When you eat, carbohydrates are digested into glucose and blood sugar rises within minutes. In people without diabetes, the pancreas releases a quick burst of insulin to match. Mealtime (also called bolus or prandial) insulin is meant to imitate that burst. It is also used for correction doses to bring down a high reading.

Mealtime insulin is standard in type 1 diabetes. In type 2 diabetes it is usually added only when basal insulin plus other medicines are no longer enough to control post-meal readings.

The mealtime insulins

Timing below is a summary of the U.S. prescribing information for each product. Your care team may give you different timing based on your readings — follow their instructions.

Rapid-acting analogs typically start working in about 15 minutes, peak at 1–2 hours, and last 3–5 hours. Ultra-rapid versions reach the blood within a few minutes and start lowering glucose a few minutes sooner, but their effect can still last about 4–7 hours. Regular insulin starts in about 30 minutes, peaks at 2–4 hours, and lasts 5–8 hours, which is why it must be taken further ahead of food and carries more risk of a low several hours after eating.

Timing: why minutes matter

Food can raise glucose faster than injected insulin starts working. If insulin is taken late, glucose spikes first and the insulin then keeps working after the meal is digested — a common pattern of a high reading followed by a low one. Some people, often those using a CGM, are advised by their care team to take mealtime insulin a little earlier before eating (sometimes called "pre-bolusing"), particularly for high-carbohydrate breakfasts. This is something to agree with your team, because taking insulin early and then delaying the meal can cause a low.

When appetite is unpredictable — illness, young children, nausea, or older adults who may not finish a meal — clinicians sometimes advise dosing right after the meal, based on what was actually eaten. Ultra-rapid insulins are labeled for use up to 20 minutes after starting a meal for this reason.

How the dose is worked out

There are two common approaches, and your care team will tell you which you are using:

• Fixed doses. A set number of units for each meal, used when meals are fairly consistent. Common when mealtime insulin is first added in type 2 diabetes.
• Flexible dosing. The dose is calculated from the carbohydrate in the meal (using an insulin-to-carb ratio) plus a correction if glucose is above target. This is standard in type 1 diabetes and is explained on the dosing and adjustment page.

Either way, the numbers are individual. Do not copy another person's doses or ratios.

Common problems

• Skipping the meal after dosing. If you take mealtime insulin and then cannot eat, you are at risk of a low. Keep fast-acting glucose with you, and know the 15-15 rule.
• Stacking. Taking another dose while the last one is still active is a common cause of unexpected lows.
• High-fat or high-protein meals. Pizza, fried foods, and large rich meals can raise glucose late — several hours after eating. Pumps can spread the dose out; on injections, your team may suggest a strategy.
• Mixing up pens. Taking a large basal dose with a rapid-acting pen (or the other way around) is a serious error. Keep pens visibly different and check the label before every dose. If it happens, contact your care team or seek urgent advice and check glucose frequently.
• Absorption differences. The abdomen absorbs fastest; rotating within the same region at each meal keeps timing consistent. See injection technique.

Mixing with other insulins

Only some mealtime insulins can be mixed. Regular insulin and some rapid-acting insulins (standard lispro U-100, aspart, and glulisine) can be drawn into the same syringe as NPH when a prescriber has recommended it — the clear insulin is drawn up first, then the cloudy NPH. The ultra-rapid insulins (Fiasp, Lyumjev), the aspart biosimilar Merilog, and concentrated Humalog U-200 must not be mixed with any other insulin. No mealtime insulin should be mixed with glargine, detemir, degludec, or a once-weekly insulin. Check your product's leaflet before mixing anything.

Frequently asked questions